Blood tests could diagnose depression


Diagnoses for clinical depression usually involve self-reported data from patients, but researchers at Northwestern University may have a better way to identify the disease.
Researchers at Northwestern University's Feinberg School of Medicine published a study today that found a link between gene markers and depression. The study, co-led by Eva Redei, a research professor at the school, found that some RNA markers were linked to clinical depression in teenagers.
Three of the gene markers could be used to determine if patients may be receptive to psychotherapy or cognitive behavioral therapy to help their depression, too: Fast Company reports that the researchers found patterns among patients who responded positively to therapy.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The results were significant: 40 percent of those with depression improved their mental health after undergoing cognitive behavioral therapy, and of those who improved their health with treatment, the researchers found a correlation between three of the RNA markers. In addition, the researchers found nine RNA markers that linked the individuals who reported having clinical depression at the start of the study.
More research is needed before doctors start administering depression blood tests, though: The study only looked at 32 people with depression and 32 in a control group. Still, the findings show promise for depression treatment in the future.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
-
Can TrumpRX really lower drug prices?
Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
‘Every argument has a rational, emotional, and rhetorical component’
Instant Opinion Opinion, comment and editorials of the day
-
October 6 editorial cartoons
Cartoons Monday’s political cartoons include bad news overload, Donald Trump repeatedly crossing a red line, and the Statue of Liberty fallen on hard times
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials